Right Sense International (00381) plans to establish a joint venture to enter the huge market of medical-grade outpatient care and digital health services

Zhitong Finance App News, Right Knowledge International (00381) announced that on September 22, 2026, the company signed a memorandum of understanding with Win & Win Life Group Limited (joint venture partner), a company incorporated in Hong Kong, regarding the establishment of a new joint venture in Hong Kong by the company (or its designated subsidiary) and the joint venture partner (or its designated subsidiary). The main business of the joint venture includes the joint venture partner's anti-aging consumer products, AI rings, and health data operations. It is reintegrated with the Group's existing business into a new business model, and the joint venture partner team unifies the supply chain, channels and operations.

The joint venture partner is a limited company incorporated in Hong Kong. As of this announcement date, the joint venture partner is positioned as a “health data asset operator”. The core technology originates from the Institute of Aging Biology at the Harvard University Research Center in the United States. Its business model combines physical anti-aging products, AI smart rings (hardware customer acquisition) and overall SaaS solutions to collect medical grade verification data such as user temperature, blood oxygen, and heart rate through 7X24, transforming human health data into value-added digital and data assets, creating a “product+data+capital” closed-loop ecosystem.

The company has a listed position in the Hong Kong capital market and has experience in health consumer products such as Chinese herbal medicine and tea; while the joint venture partner has Harvard's core technology, AI smart ring, and leading “health data capitalization (RWA) and SaaS models”. The combination of the two can quickly transform technology into physical revenue and digital assets. In line with the “Active Health and Ageing” national strategic opportunity, joint venture partners have participated deeply in national key research and development plans. By cooperating with it, the company can directly enter the huge market for medical-grade outpatient care and digital health services representing future trends.